JI

Jaid Ismail Kojar

Active Director Cfo DIN 06646692
DIN 06646692 First appointment Jul 2013 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Jul 2013
Shareholding value •••• Premium profile

About Jaid Ismail Kojar

Data last updated:

Jaid Ismail Kojar is a Cfo at Eiko Lifesciences Limited (since 2022), Nominee Director at Reflux Pharmaceuticals Private Limited (since 2024) and Director at Techvertica Technologies Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Chemicals and Materials, Pharma and Information Technology. The 4 current companies with reported revenue have a combined latest revenue of ₹59.09 Cr; the largest is Eiko Lifesciences Limited at ₹38.38 Cr (FY 2025). Earlier, Jaid Ismail Kojar was a Director at Amarnath Securities Limited (2013–2022).

DIN 06646692
Primary Designation Cfo
Industry Chemicals and Materials
First Appointment 31 Jul 2013
Oldest Company Age 49 yrs
Largest company Eiko Lifesciences Limited · ₹38.38 Cr (FY 2025)
Combined revenue ₹59.09 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eiko Lifesciences Limited L65993MH1977PLC258134
Cfo09 Feb 20221977₹38.38 Cr (FY 2025)Active
Nominee Director29 Jul 20242020₹20.56 Cr (FY 2025)Active
Director28 Mar 20252014₹7.7 Lakh (FY 2025)Active
Hio Health Private Limited U85100MH2013PTC239373
Director19 Feb 20162013₹7 Lakh (FY 2020)Active
Designated Partner30 May 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amarnath Securities Limited L67120GJ1994PLC023254
Director31 Jul 20131994₹1.18 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eiko Lifesciences Limited
Hio Health Private Limited
Techvertica Technologies Private Limited
Reflux Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jaid Ismail Kojar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaid Ismail Kojar

Jaid Ismail Kojar currently holds 5 directorships: Eiko Lifesciences Limited (Cfo, since 09 Feb 2022, revenue ₹38.38 Cr (FY 2025)); Reflux Pharmaceuticals Private Limited (Nominee Director, since 29 Jul 2024, revenue ₹20.56 Cr (FY 2025)); Techvertica Technologies Private Limited (Director, since 28 Mar 2025, revenue ₹7.7 Lakh (FY 2025)); Hio Health Private Limited (Director, since 19 Feb 2016, revenue ₹7 Lakh (FY 2020)); Eiko Scientific Solutions Llp (Designated Partner, since 30 May 2024).

Jaid Ismail Kojar was first appointed on 31 Jul 2013 as Director at Amarnath Securities Limited. The most recent appointment on record is 28 Mar 2025 at Techvertica Technologies Private Limited.

The 4 current companies of Jaid Ismail Kojar that report revenue have a combined latest revenue of ₹59.09 Cr: Eiko Lifesciences Limited ₹38.38 Cr (FY 2025); Reflux Pharmaceuticals Private Limited ₹20.56 Cr (FY 2025); Techvertica Technologies Private Limited ₹7.7 Lakh (FY 2025); Hio Health Private Limited ₹7 Lakh (FY 2020).

Jaid Ismail Kojar held 1 earlier board appointment: Amarnath Securities Limited (Director, 31 Jul 2013 to 02 Nov 2022).

The current boards of Jaid Ismail Kojar's companies include Bhavesh Dhirajlal Tanna (Eiko Lifesciences Limited), Chintan Bharatbhai Doshi (Eiko Lifesciences Limited), Hasti Arjav Doshi (Eiko Lifesciences Limited), Kajal Dhanpatraj Kothari (Eiko Lifesciences Limited), Laxmikant Ramprasad Kabra (Eiko Lifesciences Limited), Rajkumar Govindas Baheti (Eiko Lifesciences Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available